Axogen, Inc. (AXGN)

Nasdaq: AXGN · Electromedical & Electrotherapeutic Apparatus · Alachua, FL · filing with the SEC since 1995

Grade6.1

◀ Past 6.4● Present 6.6▶ Future 5.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Feb 24, 2026	Feb 26, 2025	Mar 5, 2024	Mar 14, 2023	Feb 25, 2022	Mar 1, 2021	Feb 24, 2020	Feb 26, 2019	Feb 28, 2018	Mar 1, 2017
Revenue	225,208,000	187,338,000	159,012,000	138,584,000	127,358,000	112,300,000	106,712,000	83,937,000	60,426,000^r	41,108,000^r
Cost of revenue	57,855,000	45,361,000	37,143,000^r	29,775,000^r	22,931,000	21,581,000	17,349,000	12,923,000	9,311,000	6,467,000
Gross profit	167,353,000	141,977,000	121,869,000^r	108,809,000^r	104,427,000	90,719,000	89,363,000	71,014,000	51,115,000^r	34,641,000^r
Research and development	32,885,000	27,767,000	27,339,000^r	25,627,000^r	24,177,000	17,846,000	17,514,000	11,773,000	6,699,000^r	4,212,000^r
Sales and marketing	97,740,000	78,461,000	77,580,000^r	71,983,000^r	73,328,000	69,659,000	71,950,000	56,617,000	37,636,000^r	28,426,000^r
General and administrative	44,577,000	39,036,000	38,412,000^r	40,906,000^r	32,338,000	26,396,000	31,305,000	23,124,000	14,731,000^r	10,133,000^r
Total costs and expenses	175,202,000	145,264,000	143,331,000^r	138,516,000^r	129,843,000	113,901,000	120,769,000	91,514,000	59,066,000^r	42,771,000^r
Operating income	-7,849,000	-3,287,000	-21,462,000	-29,707,000	-25,416,000	-23,182,000	-31,406,000	-20,500,000	-7,951,000^r	-8,130,000^r
Interest expense	7,702,000	8,206,000	2,835,000	624,000	1,356,000	1,054,000	40,000	1,208,000^r	2,217,000^r	5,386,000^r
Interest and investment income	1,168,000	1,141,000	1,487,000	569,000	93,000	605,000	2,364,000	1,525,000	·	·
Other income (expense), net	167,000	-199,000	-437,000	-230,000	-278,000	-38,000	·	·	-30,774	-19,625
Total non-operating income (expense)	-7,854,000	-6,677,000	-254,000	759,000	-1,569,000	-604,000	2,271,000	-1,897,000	-2,494,000^r	-6,281,000^r
Income tax expense	0	0	0	0	0	0	0	0	0	0
Net income	-15,703,000	-9,964,000	-21,716,000	-28,948,000	-26,985,000	-23,786,000	-29,135,000	-22,397,000	-10,445,000^r	-14,411,000^r
Earnings per share, basic	-0.34	-0.23	-0.51	-0.69	-0.65	-0.60	-0.74	·	·	·
Earnings per share, diluted	-0.34	-0.23	-0.51	-0.69	-0.65	-0.60	-0.74	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-0.60	-0.74	-0.60	-0.31	-0.47
Weighted average shares, basic	46,050,266	44,257,754	42,878,543	42,083,125	41,214,889^r	39,966,937^r	39,235,000	·	·	·
Weighted average shares, diluted	46,050,266	44,257,754	42,878,543	42,083,125	41,214,889^r	39,966,937^r	39,235,000	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	39,967,000	39,235,000^r	37,127,000^r	33,323^r	30,702^r

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:Revenues

Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold

Gross profit revenue less the cost of what it soldus-gaap:GrossProfit

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense

Interest and investment income what its cash and investments earned

us-gaap:InvestmentIncomeNet
us-gaap:InvestmentIncomeNonoperating

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton AXGN · research, not advice